Document is current
Any future updates will be listed below
-
Authors
Tometten, Lukas
Trost, Ulrike
Jürgens, Linda
Achterberg, Stephan
Arenz, Lukas
Audebert, Franz
Bickel, Markus
Dolff, Sebastian
Draenert, Rika
Ewering, Silke
Fischer, Julia
Friedrichs, Anette
Hagel, Stefan
Hennigs, Annette
Horn, Dagmar
Isner, Caroline
Khatamzas, Elham
Lanckohr, Christian
Lang, Henriette
Matthews, Hanna
Müller, Beate Sigrid
Neubert, Jennifer
Schmiedel, Stefan
Simon, Arne
Tepasse, Phil-Robin
Waldeck, Frederike
Lehmann, Clara
Stegemann, Miriam
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 14 June 2025
Accepted: 29 July 2025
First Online: 22 August 2025
Declarations
:
: C.L. has received honoraria for lectures at educational events or for consultancy services from MSD, Novartis, Gilead, GSK, Janssen, Pfizer, Baxter and ViiV. The author has also received research funding from the German Federal Joint Committee (G-BA) for an OPAT study (funding code FKZ: 01VSF18036). The author declares no conflicts of interest related to this publication. All other authors have no conflicts of interest to declare that are relevant to the content of this article.
